Jobbers Wholesale Issues Voluntary Recall of Rhino 5 Plus, Maxtremezen and Extenzone Marketed as a Dietary Supplement Due to the Presence of Undeclared Drug Ingredients

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Jobbers Wholesale Issues Voluntary Recall of Rhino 5 Plus, Maxtremezen and Extenzone Marketed as a Dietary Supplement Due to the Presence of Undeclared Drug Ingredients

11/18/2013 04:27 PM EST

Paramount, CA, Jobbers Wholesale is voluntarily recalling Lot No. KWAKPMC030505175957019 of Rhino 5 Plus, Lot No. JBP-L-1270-70 of Maxtremezen and Lot No. KWAKPMC03050517 of Extenzone to the consumer level. FDA analysis found these products to contain undeclared desmethylcarbondenafil and dapoxetine.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420